Cargando…

A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies

BACKGROUND: A risk score for invasive mold disease (IMD) in patients with hematological malignancies could facilitate patient screening and improve the targeted use of antifungal prophylaxis. METHODS: We retrospectively analyzed 1,709 hospital admissions of 840 patients with hematological malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanzani, Marta, Lewis, Russell E., Fiacchini, Mauro, Ricci, Paolo, Tumietto, Fabio, Viale, Pierluigi, Ambretti, Simone, Baccarani, Michele, Cavo, Michele, Vianelli, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784450/ https://www.ncbi.nlm.nih.gov/pubmed/24086555 http://dx.doi.org/10.1371/journal.pone.0075531

Ejemplares similares

Update on the treatment of disseminated fusariosis: Focus on voriconazole
por: Stanzani, Marta, et al.
Publicado: (2007)

Sinonasal risk factors for the development of invasive fungal sinusitis in hematological patients: Are they important?
por: Fernandez, Ignacio J., et al.
Publicado: (2011)

Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections
por: Ambretti, Simone, et al.
Publicado: (2019)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
por: Pascale, Renato, et al.
Publicado: (2021)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease
por: Stanzani, Marta, et al.
Publicado: (2018)

Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients
por: Coppola, Paolo E., et al.
Publicado: (2020)

Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp.
por: Viciani, Elisa, et al.
Publicado: (2022)

Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study
por: Liu, Chun, et al.
Publicado: (2023)

Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality
por: Tumbarello, Mario, et al.
Publicado: (2012)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
por: Palandri, Francesca, et al.
Publicado: (2012)

1466 Primary Cutaneous Mold Infections in Hematologic Malignancy with a Review of the Literature
por: Mai, Jane, et al.
Publicado: (2014)

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease
por: Yashphe, Eva L., et al.
Publicado: (2021)

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients
por: Montagna, M. T., et al.
Publicado: (2013)

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection
por: Bartoletti, Michele, et al.
Publicado: (2019)

Mucorales-Specific T Cells in Patients with Hematologic Malignancies
por: Potenza, Leonardo, et al.
Publicado: (2016)

Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?
por: Lewis, Russell E, et al.
Publicado: (2023)

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
por: Palandri, Francesca, et al.
Publicado: (2021)

Central Nervous System Mold Infections in Children with Hematological Malignancies: Advances in Diagnosis and Treatment
por: Luckowitsch, Marie, et al.
Publicado: (2021)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

The lower respiratory tract microbiome of critically ill patients with COVID-19
por: Gaibani, Paolo, et al.
Publicado: (2021)

Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study
por: Sollazzo, Daria, et al.
Publicado: (2016)

An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic
por: Tedeschi, Sara, et al.
Publicado: (2023)

Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature
por: Maccaro, Angelo, et al.
Publicado: (2021)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

The diagnostic role of Next Generation Sequencing in uncovering isolated splenomegaly: A case report
por: Auteri, Giuseppe, et al.
Publicado: (2021)

The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis
por: Barone, Martina, et al.
Publicado: (2020)

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly
por: Sollazzo, Daria, et al.
Publicado: (2016)

Sustained response off therapy after fostamatinib: A chronic refractory ITP case report
por: Auteri, Giuseppe, et al.
Publicado: (2023)

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
por: D'Arena, Giovanni, et al.
Publicado: (2017)

755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
por: Gupta, Aanchal, et al.
Publicado: (2022)

Risk of Immune Thrombocytopenia Relapse and Onset Related to Sars-Cov-2 Infection and Vaccination
por: Auteri, Giuseppe, et al.
Publicado: (2022)

Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study
por: Auteri, Giuseppe, et al.
Publicado: (2023)

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients
por: Gatti, Milo, et al.
Publicado: (2022)

2120. Respiratory Viral Infections in Patients with Hematologic Malignancies
por: Cardenas, Jorge Luis, et al.
Publicado: (2022)

A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia Vera
por: Barone, Martina, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ml4h0irvpi4l724te7h1r10i1u